Acumen Pharmaceuticals, Inc. (ABOS) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $88.0K | +450.0% |
| 2024 | $16.0K | -23.8% |
| 2023 | $21.0K | -87.0% |
| 2022 | $161.0K | +302.5% |
| 2021 | $40.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $88.0K | +450.0% |
| 2024 | $16.0K | -23.8% |
| 2023 | $21.0K | -87.0% |
| 2022 | $161.0K | +302.5% |
| 2021 | $40.0K | — |